Pharmacodynamics simulation of HOEC by a computational model of arachidonic acid metabolic network
- 147 Downloads
Arachidonic acid (AA) metabolic network is activated in the most inflammatory related diseases, and small-molecular drugs targeting AA network are increasingly available. However, side effects of above mentioned drugs have always been the biggest obstacle. (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate (HOEC), a natural product acted as an inhibitor of 5-lipoxygenase (5-LOX) and 15-LOX in vitro, exhibited weaker therapeutic effect in high dose than that in low dose to collagen induced arthritis (CIA) rats. In this study, we tried to elucidate the potential regulatory mechanism by using quantitative pharmacology.
First, we generated an experimental data set by monitoring the dynamics of AA metabolites’ concentration in A23187 stimulated and different doses of HOEC co-incubated RAW264.7. Then we constructed a dynamic model of A23187-stimulated AA metabolic model to evaluate how a model-based simulation of AA metabolic data assists to find the most suitable treatment dose by predicting the pharmacodynamics of HOEC.
Compared to the experimental data, the model could simulate the inhibitory effect of HOEC on 5-LOX and 15-LOX, and reproduced the increase of the metabolic flux in the cyclooxygenase (COX) pathway. However, a concomitant, early-stage of stimulation-related decrease of prostaglandins (PGs) production in HOEC incubated RAW264.7 cells was not simulated in the model.
Using the model, we predict that higher dose of HOEC disrupts the flux balance in COX and LOX of the AA network, and increased COX flux can interfere the curative effects of LOX inhibitor on resolution of inflammation which is crucial for the efficient and safe drug design.
Keywordsarachidonic acid metabolic network computational model anti-inflammation natural product
The research is supported in part by the National Key Research and Development Program (No. 2016YFA0502304), Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase, No.U1501501), and the National Natural Science Foundation of China (No. 21173076). Honglin Li is also sponsored by National Program for Special Supports of Eminent Professionals and National Program for Support of Top-notch Young Professionals.
- 7.Guay, J., Bateman, K., Gordon, R., Mancini, J. and Riendeau, D. (2004) Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J. Biol. Chem., 279, 24866–24872CrossRefGoogle Scholar
- 12.Palmblad, J., Malmsten, C. L., Udén, A. M., Rådmark, O., Engstedt, L. and Samuelsson, B. (1981) Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood, 58, 658–661Google Scholar
- 15.Sozzani, S., Zhou, D., Locati, M., Bernasconi, S., Luini, W., Mantovani, A. and O’Flaherty, J. T. (1996) Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and-3. J. Immunol., 157, 4664–4671Google Scholar
- 18.Singh, D. (2004) Merck withdraws arthritis drug worldwide. BMJ, 329, 816.2Google Scholar
- 33.Kramer, R. M., Roberts, E. F., Um, S. L., Börsch-Haubold, A. G., Watson, S. P., Fisher, M. J. and Jakubowski, J. A. (1996) p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem., 271, 27723–27729Google Scholar
- 35.Tokuda, H., Kozawa, O. and Uematsu, T. (2000) Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J. Bone Miner. Res., 15, 2371–2379CrossRefGoogle Scholar
- 36.Shen, J.-N., Xu, L.-X., Shan, L., Zhang, W.-D., Li, H.-L. and Wang, R. (2015) Neuroprotection of (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate against hydrogen peroxide and lipopolysaccharide induced injury via modulating arachidonic acid network and p38-MAPK signaling. Curr. Alzheimer Res., 12, 892–902CrossRefGoogle Scholar
- 37.Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., Katayama, T., Araki, M. and Hirakawa, M. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 34, D354–D357Google Scholar
- 41.Rossi, A., Pergola, C., Koeberle, A., Hoffmann, M., Dehm, F., Bramanti, P., Cuzzocrea, S., Werz, O. and Sautebin, L. (2010) The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br. J. Pharmacol., 161, 555–570CrossRefGoogle Scholar
- 49.De Micheli, G. and Benini, L. (2006) Networks on Chips: Technology and Tools. Academic Press.Google Scholar